PROVECTUS BIOPHARMACEUTICALS INC WTS (DE)
PVCT.WS
PVCT.WS was delisted on the 13th of October, 2016.
4 hedge funds and large institutions have $547K invested in PROVECTUS BIOPHARMACEUTICALS INC WTS (DE) in 2016 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, reducing their positions, and closing their positions.
33% more funds holding
Funds holding: 3 → 4 (+1)
1% more capital invested
Capital invested by funds: $540K → $547K (+$7K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Creative Planning
Overland Park,
Kansas
|
+$32.8K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$1.12K |
Top Sellers
PVCT.WS Hedge Fund Activity: Q2 2016 in Review
4 of the 3,756 institutional investors tracked by Wall St. Rank reported a position in PROVECTUS BIOPHARMACEUTICALS INC WTS (DE) (PVCT.WS) for Q2 2016, worth a combined $547K — up 1.3% from $540K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new PVCT.WS positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Creative Planning, opening a new position worth an estimated $32.8K.
- 4 institutional investors held PROVECTUS BIOPHARMACEUTICALS INC WTS (DE) (PVCT.WS) as of Q2 2016, up from 3 in Q1 2016.
- Funds reported $547K of PROVECTUS BIOPHARMACEUTICALS INC WTS (DE) stock for Q2 2016, up 1.3% quarter-over-quarter.
- 1 fund opened new PROVECTUS BIOPHARMACEUTICALS INC WTS (DE) positions in Q2 2016 and 0 closed out, a net change of +1 holder.
- The largest PROVECTUS BIOPHARMACEUTICALS INC WTS (DE) buyer in Q2 2016 was Creative Planning, an estimated $32.8K added.
Based on aggregated 13F filings for Q2 2016.